We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
Corneal light scattering after laser in situ keratomileusis and photorefractive keratectomy.
American Journal of Ophthalmology 1995 October
PURPOSE: To compare corneal light scattering after laser in situ keratomileusis and photorefractive keratectomy in rabbit eyes.
METHODS: For laser in situ keratomileusis, a 5-mm, -10-diopter spherorefractive resection was performed on the stromal bed under a corneal flap. Corneal light scattering was objectively measured for 12 weeks, and compared to corneal light scattering after photorefractive keratectomy (5 mm, -10 diopters).
RESULTS: Corneal light scattering was significantly lower in the laser in situ keratomileusis group than in the photorefractive keratectomy group at all time points after surgery (P < .01 at weeks 1 through 6, and P = .03 at week 12).
CONCLUSIONS: In this experimental study, laser in situ keratomileusis resulted in significantly less corneal light scattering than photorefractive keratectomy.
METHODS: For laser in situ keratomileusis, a 5-mm, -10-diopter spherorefractive resection was performed on the stromal bed under a corneal flap. Corneal light scattering was objectively measured for 12 weeks, and compared to corneal light scattering after photorefractive keratectomy (5 mm, -10 diopters).
RESULTS: Corneal light scattering was significantly lower in the laser in situ keratomileusis group than in the photorefractive keratectomy group at all time points after surgery (P < .01 at weeks 1 through 6, and P = .03 at week 12).
CONCLUSIONS: In this experimental study, laser in situ keratomileusis resulted in significantly less corneal light scattering than photorefractive keratectomy.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis.Critical Care Medicine 2024 Februrary 8
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app